Chemosensitivity of human hepatocellular carcinoma cell line QGY-7703 is related to bcl-2 protein levels

被引:14
作者
Luo, D [1 ]
Cheng, SCS [1 ]
Xie, H [1 ]
Xie, Y [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Peoples R China
关键词
apoptosis; Bcl-2; protein; chemosensitivity; doxorubicin; hepatocellular carcinoma; taxol; transfection;
D O I
10.1159/000030097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bcl-2 protein is one of the major apoptosis regulators, The study examines the effect of Bcl-2 protein on the chemosensitivity of a human hepatocellular carcinoma cell line, QGY-7703. Western blot analysis showed that Bcl-2 and Bar proteins were expressed in QGY-7703 cells. Characteristic features of Taxol- and doxorubicin-induced apoptosis were evidenced by the Annexin-V binding assay, TUNEL and DAPI staining. At constant Bar protein levels, stable sense and antisense gene-transfected QGY-7703 cells showed that constitutive expression of Bcl-2 could render the cells more resistant to Taxol and doxorubicin, Contrarily, decreased Bcl-2 levels caused the cells to be more sensitive to the drugs. As Bcl-2 levels are directly proportional to the resistance of QGY-7703 cells to Taxol and doxorubicin, manipulation of Bcl-2 could be performed to enhance the sensitivity of liver cancer to chemotherapeutic agents. Copyright (C) 1999 S. Karger AG, Basel.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 39 条
[1]  
[Anonymous], 2007, Biostatistical analysis
[2]   Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-X(L) [J].
Benito, A ;
Silva, M ;
Grillot, D ;
Nunez, G ;
FernandezLuna, JL .
BLOOD, 1996, 87 (09) :3837-3843
[3]  
CAMPOS L, 1993, BLOOD, V81, P3091
[4]  
CASTLE VP, 1993, AM J PATHOL, V143, P1543
[5]  
CHARLOTTE F, 1994, AM J PATHOL, V144, P460
[6]  
CHLEBOWSKI RT, 1984, CANCER TREAT REP, V68, P487
[7]  
DOLE M, 1994, CANCER RES, V54, P3253
[8]  
Haldar S, 1996, CANCER RES, V56, P1253
[9]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[10]   PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].
HOLMES, FA ;
WALTERS, RS ;
THERIAULT, RL ;
FORMAN, AD ;
NEWTON, LK ;
RABER, MN ;
BUZDAR, AU ;
FRYE, DK ;
HORTOBAGYI, GN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1797-1805